News from alimera sciences, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 28, 2015, 16:05 ET

Alimera Sciences to Release First Quarter 2015 Financial Results

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Apr 21, 2015, 17:10 ET
http://www.multivu.com/players/English/7496251-iluvien-dme/gallery/image/2535f9d6-85db-4380-9b62-e598697ec47d.HR.jpg

ILUVIEN® Is Now Widely Available To Diabetic Macular Edema Patients Throughout The U.S.

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of...

Apr 14, 2015, 08:00 ET

Alimera Sciences' ILUVIEN® Receives 17th European Marketing Authorization; Completing Second Wave Of Country Approvals

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Mar 19, 2015, 11:55 ET

Alimera Sciences to Host Analyst and Investor Luncheon on Wednesday, March 25, 2015 in New York City

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Mar 04, 2015, 16:28 ET

Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of...

Feb 23, 2015, 16:05 ET

Alimera Sciences To Release Fourth Quarter And Fiscal Year 2014 Financial Results

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of...

Feb 23, 2015, 16:01 ET

Alimera Sciences To Present At 2015 Cowen Healthcare Conference

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Feb 17, 2015, 08:00 ET

Alimera Sciences To Host ILUVIEN® Live Webinar Launch Event

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Jan 26, 2015, 14:00 ET

Alimera Sciences' ILUVIEN® Receives Marketing Authorization in Finland and Luxembourg

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Jan 14, 2015, 11:48 ET

Alimera Sciences Announces First Sale of ILUVIEN® in Portugal

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and...

Dec 16, 2014, 08:30 ET

Alimera Sciences Added to NASDAQ Biotechnology Index

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of...

Dec 15, 2014, 08:45 ET

Alimera Sciences Announces Closing of $50.0 Million Financing with Deerfield Management

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Dec 01, 2014, 15:00 ET

Alimera Sciences' ILUVIEN® Receives Marketing Authorization In The Netherlands For The Treatment Of Chronic Diabetic Macular Edema

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Nov 28, 2014, 08:30 ET

Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of...

Nov 17, 2014, 11:45 ET

Alimera Sciences' ILUVIEN® Receives Marketing Authorization In Ireland For The Treatment Of Chronic Diabetic Macular Edema

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Nov 12, 2014, 07:30 ET

Alimera Sciences' ILUVIEN® Receives Marketing Authorization In Belgium For The Treatment Of Chronic Diabetic Macular Edema

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Nov 06, 2014, 16:13 ET

Alimera Sciences Reports Third Quarter 2014 Financial Results

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Oct 23, 2014, 16:15 ET

Alimera Sciences to Release Third Quarter 2014 Results

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Oct 09, 2014, 08:30 ET

Alimera Sciences to Present at Ophthalmology Innovation Summit at the American Academy of Ophthalmology Annual Meeting

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of...

Sep 30, 2014, 13:50 ET

Alimera Sciences Receives $25 Million Advance from Hercules Technology Growth Capital

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...